The findings of the article are presented clearly and concise. However, there are some points that need to be addressed by the authors:
1) The introduction is very straightforward but falls short on delivering a comprehensive picture on the topic. For example, there is a body of research on psychological insulin resistance that is relevant for discussing satisfaction. Also, previous studies should be discussed in more detail in order to set the stage for the specifics of insulin therapy and allow for comparison with previously found determinants of satisfaction. The introduction and discussion would benefit from a more wider approach.
2) There is a bit of redundancy at the end of the "analyses" section.
3) Albeit insulin therapy seems not to be associated with overall satisfaction, it would be interesting to compare the DTSQ items across the insulin therapy regimens. This analysis would enable the authors to make more precise distinctions regarding their statement on page 15 "patients on insulin therapy are less flexible with regard to their diet and physical activity". 4) My impression was that all patients on insulin therapy from the GUIDANCE study were included in this analysis. However, on page 11 the authors report a mean DTSQ score of "28.88" for those using insulin" for the GUIDANCE sample but the current sample had a mean DTSQ score of "28.50". Were there inclusion/exclusion criteria for this analysis?
5) The reason for the sensitivity analyses is not clearly established.
What was the initial hypothesis for this analysis? Furthermore, the finding of the sensitivity analyses should be discussed in more detail. How do the authors interpret the finding and what can be drawn from it? 6) Duration of insulin treatment is missing as a covariate and is not even discussed as a potential covariate or listed as a limitation. Can the authors comment on this? 7) On the one hand only analyzing patients on insulin therapy is interesting, but on the other hand no inferences can be made about the specificity of associated factors. Are the associations found in this analysis specific for people on insulin therapy, or are these general factors of satisfaction with diabetes therapy? Again, it would be helpful to learn more about factors associated with satisfaction found in other studies; or by including a matched non-insulin-treated "control group"… 8) The authors should include effect sizes (and SD) in Table 2 (for the group comparisons). This would allow a more realistic interpretation of the strengths of the associations. For example, the difference regarding macrovascular complications is extremely small (28.91 vs. 28.29) and the clinical relevance can be questioned.
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GENERAL COMMENTS
Boels et al conducted an observational study of 1984 type 2 diabetic patients on insulin therapy to determine factors associated with treatment satisfaction. A higher DTSQ score was positively associated with diabetes education, macrovascular compications and a better health status, whereas a lower score was associated with poor glycaemic control and more frequently perceived of hypoglycemia.
1. The topic is interesting, but results are quite obviuos. One interesting finding regards the lack of association between insulin regimen and treatment satisfaction. All insulin regimens are able to lower HbA1c, and none is better than other to increase treatment satisfaction. This should be discussed some more. 2. The DTSQ item on flexibility has been rated lowest, suggesting that insulin therapy could be limited by a low flexibility. In type 1 diabetes, insulin therapy with insulin pump was associated with a higher treatment satisfaction than multiple daily injections of insulin (Diabet Med. 2008; 25:213-20; Endocrine. 2014; 46:256-62) This should be pointed out in the discussion
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
1) The introduction is very straightforward but falls short on delivering a comprehensive picture on the topic. For example, there is a body of research on psychological insulin resistance that is relevant for discussing satisfaction. Also, previous studies should be discussed in more detail in order to set the stage for the specifics of insulin therapy and allow for comparison with previously found determinants of satisfaction. The introduction and discussion would benefit from a more wider approach. > We have expanded the background and added information on psychological insulin resistance and diabetes-related distress. In addition we now briefly described similar studies that have been published on treatment satisfaction.
2) There is a bit of redundancy at the end of the "analyses" section. > We would like to thank the reviewer for this comment. We have now edited the analyses section.
3) Albeit insulin therapy seems not to be associated with overall satisfaction, it would be interesting to compare the DTSQ items across the insulin therapy regimens. This analysis would enable the authors to make more precise distinctions regarding their statement on page 15 "patients on insulin therapy are less flexible with regard to their diet and physical activity". > We have created a new table (Table 2 on page 26), in which the scores on the different DTSQ items are compared across the different insulin regimens. We concluded: "The proportion of patients who were satisfied for each component of the DTSQ items ranged from 79.8% (DTSQ item 5 "flexibility") to 87.4% (DTSQ item 1 "overall satisfaction"). There was no difference between different insulin regimen groups with regard to the total DTSQ score and the scores on separate components of the DTSQ (Table 2) ." (results section, page 12).
4) My impression was that all patients on insulin therapy from the GUIDANCE study were included in this analysis. However, on page 11 the authors report a mean DTSQ score of "28.88" for those using insulin" for the GUIDANCE sample but the current sample had a mean DTSQ score of "28.50". Were there inclusion/exclusion criteria for this analysis? > We understand these numbers are confusing. We tried to make the difference clear by stating "(complete cases)", but this is probably still too vague. From the original GUIDANCE dataset, we created a dataset with only the individuals on insulin therapy. In this new dataset, we have performed multiple imputations. However, to investigate whether patients on insulin therapy were indeed less satisfied than their counterparts, we performed a T-test in the original GUIDANCE dataset, which has missing data. Therefore, the mean difference of 28.88 is the value of the complete cases, and 28.50 is the value of all individuals on insulin therapy after multiple imputation.
We have now edited the text of the result section to explain this difference in more detail, as follows: "In the total sample from the GUIDANCE study (n=7597), the mean DTSQ score was 28.88 ±5.77 for those using insulin and 30.42 ±5.37 for those not using insulin (p<0.001)). In the separate database of patients on insulin, we imputed all missing data. As a result, we counted DTSQ scores of people who did not have a score in the total sample database. Doing so, the mean DTSQ score was 28.50 ±7.52." (results section, page 12).
5) The reason for the sensitivity analyses is not clearly established. What was the initial hypothesis for this analysis? Furthermore, the finding of the sensitivity analyses should be discussed in more detail. How do the authors interpret the finding and what can be drawn from it? > We hypothesized that the association between total DTSQ score and having received diabetes education could be largely explained by the association between DTSQ item six ("how satisfied are you with your understanding of diabetes?") and having received diabetes education. If this hypothesis could be confirmed, the association between total DTSQ score and diabetes education would be attenuated after omitting DTSQ item six. We have added a p-value to the results of the sensitivity analysis and interpreted this in the discussion section, as follows: "Even when the DTSQ item "understanding of diabetes" was omitted, a statistically significant positive association between diabetes education and treatment satisfaction remained. This suggests that diabetes education is more than solely the transmission of knowledge; it is also about providing patients with the ability and skills that are necessary for proper diabetes management" (discussion section, interpretation of results, page 17).
6) Duration of insulin treatment is missing as a covariate and is not even discussed as a potential covariate or listed as a limitation. Can the authors comment on this? > The reviewer is correct to suggest that duration of insulin treatment may be an important factor. Unfortunately, duration of insulin treatment was not collected for the original GUIDANCE study. We added as a limitation of the current study in the discussion as follows: "Lastly, data on duration of insulin treatment were not available, which might have been influential, as previous research showed that the burden of insulin treatment is reduced by experience" (discussion section, strengths and limitations, page 14).
7) On the one hand only analyzing patients on insulin therapy is interesting, but on the other hand no inferences can be made about the specificity of associated factors. Are the associations found in this analysis specific for people on insulin therapy, or are these general factors of satisfaction with diabetes therapy? Again, it would be helpful to learn more about factors associated with satisfaction found in other studies; or by including a matched non-insulin-treated "control group"… > The question the reviewer raises falls beyond the scope of our study. We wanted to determine factors associated with treatment satisfaction in individuals on insulin therapies, not whether these factors differ between those on insulin compared to other therapies. However, in both the introduction and the discussion section (comparison with existing literature) we have mentioned some factors found by other studies, as follows: "T2DM patients with higher glycosylated haemoglobin (HbA1c) levels and higher weight were less satisfied, similar to those with diabetes complications. Women had lower scores on the Diabetes Treatment Satisfaction Questionnaire (DTSQ) compared to men. One study found that younger patients were less satisfied with their diabetes treatment, while two other studies found that older patients were less satisfied. Several other factors are associated with diabetes treatment satisfaction, e.g. treatment in hospital, difficulties in taking medication and educational level. Only one study studied patients on insulin therapy separately: the authors performed a subgroup analysis restricted to insulin-treated patients in which they found that selfmonitoring of blood glucose and self-management of insulin doses were associated with higher DTSQ scores, while no association for the number of insulin injections was found."(introduction section, page 7), and "Our finding, that higher HbA1c levels were associated with lower treatment satisfaction, is in line with the results of other studies. Similar to our results, Nicolucci et al. found that general health perception score, measured with the SF-36 Health Survey, and DTSQ scores were positively correlated; we found a positive correlation between health status measured with the EQ-5D-VAS, and DTSQ score." (discussion section, comparison with existing literature, page 15)
8) The authors should include effect sizes (and SD) in Table 2 (for the group comparisons). This would allow a more realistic interpretation of the strengths of the associations. For example, the difference regarding macrovascular complications is extremely small (28.91 vs. 28.29) and the clinical relevance can be questioned. > For linear regression, the regression coefficient (β) is the effect measure, similar to the odds ratio for logistic regression. In the previous version of the manuscript, we added or subtracted the β from the intercept because we thought that this was easier to interpret for many readers. In the new version of the manuscript we have decided to report the βs for all factors to show the size of effect more clearly. We also included the 95% confidence interval for these β coefficients. We agree with the reviewers comment on the clinical relevance, and we have described this in our first limitation: "First, the factors included in our model only explained small differences in DTSQ score (maximum β 1.64 for diabetes education). So, while diabetes education, macrovascular complications, health status, perceived hyperglycaemia, and HbA1c levels are important factors in treatment satisfaction, there are many other unmeasured factors not examined in this study. These may be factors similar to those that are associated with psychological insulin resistance such as health beliefs and feelings of failure" (discussion section, strengths and limitations, page 14).
